In simple terms, nasal polyps are unhealthy sinus tissue that grows inside the nose, says Jean Kim, MD, PhD , an associate professor of otolaryngology at Johns Hopkins Medicine in Baltimore.

Notice how the polyps exhibit a glistening ... Also note opacification of the maxillary and ethmoid sinuses. Cuts through the expected locations of the frontal and sphenoid sinuses revealed ...

What you may think are allergies or a cold, could be the sign of nasal polyps. Nasal polyps are non-cancerous growths that line the nasal passages and sinuses. They are soft, painless, and hang ...

Nasal polyps are soft, painless growths on the lining of your nasal passages or sinuses, often resulting from chronic inflammation. While these benign growths themselves are not harmful ...

Your healthcare provider may also use a fiber optic scope to visualize inside your nose and sinus cavities. Treatment of ...

Topline results from a phase 3 trial show that tezepelumab statistically significantly reduced the size of nasal polyps and nasal congestion in adults with chronic rhinosinusitis with nasal polyps ...

Your sphenoid sinuses are behind your eyes, in your skull. Your ethmoid sinuses are behind the bridge of your nose. A sphenoid and ethmoid sinus massage can help relieve congestion in both areas.

Fungal cultures contained Curvularia. Axial CT scan through the ethmoid sinuses revealing complete opacification of the right anterior and posterior ethmoids as well as the right sphenoid sinus.

Amgen (AMGN) and AstraZeneca's (AZN) asthma therapy Tezspire hits main goals in the Phase 3 trial for chronic rhinosinusitis ...

GSK’s blockbuster hopes for depemokimab remain on track after the investigational long-acting asthma treatment has also been shown to reduce nasal polyps in a pair of phase 3 trials. The ANCHOR ...

Sanofi and Regeneron’s attempts to make Dupixent into a blockbuster franchise have been boosted with more strong phase 3 results in patients with chronic rhinosinusitis with nasal polyps (CRSwNP).

Company continues to focus on upcoming results from ENLIGHTEN 2 pivotal Phase 3 trial in CRS patients expected in 2Q 2025 <li /> Compa ...